1200 students from 50 universities Participating at DUPHAT 2017
The 22nd edition of DUPHAT Conference and Exhibition continued on its second day at the Dubai International Convention and Exhibition Centre with a remarkable participation of 1200 students from 50 universities, pharmaceutical colleges, and 25 schools in the scientific activities held parallel to the conference. The event is the ultimate platform for pharmacists, drug manufacturers, and suppliers who were keen to know about the latest updates in the pharmaceutical industry.
DUPHAT scientific program this year was rich featuring 172 scientific sessions and 36 workshops that covered several pharmaceutical topics, in addition to 612 poster presentations. The conference witnesses the participation of 168 local and international speakers.
In this scope, Dr. Ali Al Sayed, Director of Pharmaceutical Services Department at the Dubai Health Authority and the Conference Chairman said: “DUPHAT scientific program comprises pharmacy workshops, managerial skills workshop, parallel scientific presentations, professional faculty and student poster session, student poster competition and student short oral presentation competitions.
Dr. Ali Al Sayed added: “On the other hand, the latest technical information from the pharmaceutical industry was highlighted in the exhibition which hosted multinational pharmaceutical companies from the region. In addition to that, several schools from Dubai participated with healthcare exhibits and cultural activities.”
The conference has also witnessed a remarkable participation from GCC delegates in scientific sessions that were presented by pharmaceutical societies and associations from Saudi, Kuwait, Oman, and Bahrain. The sessions featured and discussed the results of Pharma case studies in the GCC, like: Determining the Prevalence of Polypharmacy among Elderly in Bahrain, Antimicrobial Stewardship Program in Oman: Are We There Yet, The role of Drug Inspection Administration in Combating, Counterfeited Drugs in Kuwait and many others.
About his session, Dr. Abdullah Al-Ajmi from Oman said: “Antimicrobial resistance is an emerging threat to the whole world and the number of new antibiotics that are being introduced to the market is very small. Doctors must learn to optimize the use of antibiotics by applying specific interventions like choosing the right antibiotic based on culture tests, or restricting the use of antibiotics altogether, among other methods. Based on common behavioral traits in our region, Antimicrobial resistance can very well become an epidemic and we need to discuss it now and reach recommendations and action plans for auditing and ensuring the rational use of antibiotics.”
In addition to that, the running parallel exhibition featured the latest and most up to date technologies in the pharmaceutical industry displayed by 600 companies from more than 75 countries.